Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Ltd

₹ 384 -0.53%
24 Jun - close price
About

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Key Points

Market Position
The Co. is the 1st Indian enzyme company with 2nd highest market share in India. It is the 2nd listed integrated enzyme player globally. [1]

  • Market Cap 4,299 Cr.
  • Current Price 384
  • High / Low 425 / 268
  • Stock P/E 29.9
  • Book Value 118
  • Dividend Yield 1.04 %
  • ROCE 15.0 %
  • ROE 11.2 %
  • Face Value 2.00

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 3.25 times its book value
  • The company has delivered a poor sales growth of 8.26% over past five years.
  • Company has a low return on equity of 10.6% over last 3 years.
  • Dividend payout has been low at 9.72% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -11.9%
  • Working capital days have increased from 193 days to 342 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
133 137 127 134 132 121 139 142 139 147 158 161 158
78 74 78 85 91 90 99 100 95 103 107 107 102
Operating Profit 55 63 49 49 40 31 40 42 44 44 51 54 55
OPM % 41% 46% 39% 37% 31% 26% 29% 29% 32% 30% 32% 33% 35%
2 1 1 1 3 2 4 9 7 7 6 14 -6
Interest 0 0 0 0 1 1 1 1 1 1 1 1 1
Depreciation 9 8 9 9 9 9 9 9 8 9 9 9 9
Profit before tax 48 55 41 41 34 24 34 40 42 41 48 59 40
Tax % 29% 27% 27% 31% 26% 26% 23% 31% 24% 29% 27% 28% 25%
34 40 30 29 25 18 26 28 32 29 35 42 30
EPS in Rs 2.81 3.40 2.66 2.46 2.19 1.60 2.34 2.63 2.87 2.58 3.08 3.74 2.53
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
219 239 222 293 329 391 420 444 502 529 541 624
130 189 131 155 177 226 236 241 269 327 382 419
Operating Profit 90 50 91 138 152 165 184 203 233 203 158 204
OPM % 41% 21% 41% 47% 46% 42% 44% 46% 46% 38% 29% 33%
4 1 1 -3 3 1 5 6 9 6 21 22
Interest 10 13 9 8 4 9 5 4 3 3 3 3
Depreciation 8 10 9 9 13 18 21 26 29 35 35 35
Profit before tax 76 28 74 118 137 139 162 179 210 171 140 188
Tax % 34% 23% 31% 35% 32% 33% 28% 26% 28% 28% 26% 27%
50 21 51 77 93 94 116 133 151 124 104 137
EPS in Rs 4.52 1.85 4.60 6.97 8.20 8.07 9.95 11.58 13.06 10.70 9.45 11.92
Dividend Payout % 7% 6% 4% 3% 5% 6% 6% 5% 7% 9% 11% 9%
Compounded Sales Growth
10 Years: 10%
5 Years: 8%
3 Years: 8%
TTM: 15%
Compounded Profit Growth
10 Years: 22%
5 Years: 5%
3 Years: 0%
TTM: 34%
Stock Price CAGR
10 Years: %
5 Years: 18%
3 Years: -2%
1 Year: 40%
Return on Equity
10 Years: 15%
5 Years: 13%
3 Years: 11%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 22 22 22 22 22 22 22 22 22 22 22 22
Reserves 140 145 188 256 442 537 657 817 949 1,066 1,213 1,302
186 167 115 101 54 67 35 28 28 35 34 47
48 73 92 71 65 102 91 104 150 137 142 164
Total Liabilities 396 406 417 450 583 727 805 971 1,149 1,260 1,411 1,535
287 287 287 285 421 491 495 563 604 619 649 660
CWIP 2 2 5 7 8 11 10 10 10 15 22 31
Investments 0 0 0 0 0 0 111 124 121 102 360 403
107 117 125 158 153 226 188 275 414 524 380 442
Total Assets 396 406 417 450 583 727 805 971 1,149 1,260 1,411 1,535

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
41 43 54 93 107 116 129 141 163 122 140 141
-40 -25 -15 -10 -60 -60 -124 -43 -27 2 -286 -65
-3 -20 -36 -63 -65 -2 -43 -39 -26 -48 -26 -59
Net Cash Flow -2 -1 2 21 -18 54 -38 60 109 75 -171 17

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 65 49 61 52 55 55 51 61 63 61 68 58
Inventory Days 318 387 403 358 352 339 363 361 346 402 343 375
Days Payable 121 81 89 68 57 78 46 43 56 60 67 40
Cash Conversion Cycle 262 356 374 342 351 315 369 379 353 404 344 393
Working Capital Days 95 5 -4 40 106 82 90 100 104 122 117 342
ROCE % 26% 12% 25% 36% 31% 25% 24% 22% 22% 15% 12%

Shareholding Pattern

Numbers in percentages

16 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
52.30% 52.55% 52.71% 52.70% 52.70% 49.88% 49.88% 49.88% 46.52% 45.92% 43.62% 43.50%
16.40% 16.27% 16.39% 18.01% 18.72% 21.68% 21.74% 21.86% 21.89% 22.27% 22.54% 23.01%
8.46% 8.66% 8.99% 6.90% 6.26% 5.60% 5.64% 5.73% 7.58% 6.49% 6.98% 7.56%
22.84% 22.52% 21.91% 22.38% 22.32% 22.86% 22.76% 22.54% 24.02% 25.34% 26.88% 25.95%
No. of Shareholders 79,25487,11284,34686,57384,37684,27781,18377,53775,05272,64273,03468,640

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls